CML is driven by the Philadelphia (Ph) chromosome, which results in the generation of the BCR-ABL fusion oncogene and expression of the constitutively active BCR-ABL tyrosine kinase. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.